SHP2 protein degrader-1
Modify Date: 2024-01-21 21:51:15
SHP2 protein degrader-1 structure
|
Common Name | SHP2 protein degrader-1 | ||
|---|---|---|---|---|
| CAS Number | 2624181-69-5 | Molecular Weight | 908.83 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C42H51Cl2N11O8 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of SHP2 protein degrader-1SHP2 protein degrader-1 is a potent allosteric inhibitor of SHP2. SHP2 protein degrader-1 induces SHP2 degradation and cell apoptosis. SHP2 protein degrader-1 has the potential for researching SHP2 related diseases[1]. |
| Name | SHP2 protein degrader-1 |
|---|
| Description | SHP2 protein degrader-1 is a potent allosteric inhibitor of SHP2. SHP2 protein degrader-1 induces SHP2 degradation and cell apoptosis. SHP2 protein degrader-1 has the potential for researching SHP2 related diseases[1]. |
|---|---|
| Related Catalog | |
| Target |
SHP2[1] |
| In Vitro | SHP2 protein degrader-1 (compound SP4) (0-200 μM; 24 hours) inhibits the growth of Hela cells, with IC50 of 5.77 and 4.30 nM, respectively, which are about 100 times higher than the activity of SHP099 (SHP2 inhibitor)[1]. SHP2 protein degrader-1 (compound SP4) (0-200 μM; 96 hours) induces 54.01% apoptotic death compared with 0.13% of the control at 100 nM[1]. SHP2 protein degrader-1 (compound SP4) (0-200 μM; 96 hours) induces cell cycle arrested at the G1 phase in Hela cells[1]. SHP2 protein degrader-1 (compound SP4) (0-200 μM; 96 hours) significantly inhibits the phosphorylation of JNK, Erk and p38[1]. SHP2 protein degrader-1 (compound SP4) (0-200 μM; 96 hours) inhibits RAS/MAPK signaling and cellular responses by a mechanism involving inhibition of SHP2 catalytic activity[1]. Cell Viability Assay[1] Cell Line: Hela cells Concentration: 0-200 μM Incubation Time: 24 hours Result: Strongly inhibited the growth of Hela cells, with IC50 of 5.77 and 4.30 nM, respectively, which were about 100 times higher than the activity of SHP099 (SHP2 inhibitor). Apoptosis Analysis[1] Cell Line: Hela cells Concentration: 0-100 μM Incubation Time: 96 hours Result: Induced 54.01% apoptotic death compared with 0.13% of the control at 100 nM. While SHP099 at 1000 nM could induce 33.74% apoptotic death compared with 0.13% of the control. Cell Cycle Analysis[1] Cell Line: Hela cells Concentration: 0-100 μM Incubation Time: 96 hours Result: Induced cell cycle arrested at the G1 phase in Hela cells. Western Blot Analysis[1] Cell Line: Hela cells Concentration: 0-100 μM Incubation Time: 96 hours Result: Significantly inhibited the phosphorylation of JNK, Erk and p38. |
| References |
[1]. Zheng M, et al. Novel PROTACs for degradation of SHP2 protein. Bioorg Chem. 2021;110:104788. |
| Molecular Formula | C42H51Cl2N11O8 |
|---|---|
| Molecular Weight | 908.83 |